Andrew Witty led GlaxoSmithKline for roughly a decade. Photo: Fabrice Coffrini / AFP via Getty Images

One year after leaving British pharmaceutical giant GlaxoSmithKline, Andrew Witty is becoming CEO of Optum, the conglomerate owned by UnitedHealth Group. One of Optum's largest businesses is its pharmacy benefit manager, which negotiates down drug prices from companies like GlaxoSmithKline.

Why it matters: Witty, a critic of high drug prices who also is a paid UnitedHealth board member, is moving to the other side of the pharmaceutical bargaining table. It's also worth noting that under Witty's watch, GlaxoSmithKline had to pay China a $489 million fine over bribery and corruption charges.

Go deeper

Ina Fried, author of Login
6 mins ago - Technology

Amazon wants to flood America with Alexa cameras and microphones

Photo: Amazon

In a Thursday event unveiling a slew of new home devices ahead of the holidays, Amazon made clearer than ever its determination to flood America with cameras, microphones and the voice of Alexa, its AI assistant.

The big picture: Updating popular products and expanding its range to car alarms and in-home drones, Amazon extended its lead in smart home devices and moved into new areas including cloud gaming and car security. The new offerings will also fuel criticism that the tech giant is helping equip a society built around surveillance.

Ben Geman, author of Generate
59 mins ago - Energy & Environment

Oil's turbulent long-term future

Illustration: Aïda Amer/Axios

The oil sector is facing risks from all sides.

Why it matters: Risk in the industry is nothing new. But these are especially turbulent and uncertain times. The industry's market clout has waned, the future of demand is kind of a mystery, and future U.S. policy is too, just to name three.

Meadows on Wray's voter fraud dismissal: "He has a hard time finding emails in his own FBI"

White House chief of staff Mark Meadows dismissed FBI Director Chris Wray's testimony that the U.S. has never historically seen evidence of widespread voter fraud, including by mail, during an appearance on "CBS This Morning" on Friday.

Why it matters: Meadows' statement highlights the Trump administration's strategy to sow doubt in November's election results by challenging the legitimacy of mail-in ballots, which are expected to skew heavily in Democrats' favor.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!